New class of drug leads to reduced risk of death for bladder cancer – study

New class of drug leads to reduced risk of death for bladder cancer – study (Peter Byrne/PA)

A new type of drug that helps target chemotherapy directly to cancer cells significantly increases survival of patients with the most common form of bladder cancer, new research suggests.

The risk of death was 30% lower with the new drug than with chemotherapy, with an average survival of approximately 13 months for the new drug, according to the new study.